皮下注射阿扑吗啡作为帕金森综合征中多巴胺能反应性的诊断试验。 - Suppr

Suppr

超能文献

Subcutaneous apomorphine as a diagnostic test for dopaminergic responsiveness in parkinsonian syndromes.

作者信息

Barker R, Duncan J, Lees A

出版信息

Lancet. 1989 Mar 25;1(8639):675. doi: 10.1016/s0140-6736(89)92183-1.

DOI:10.1016/s0140-6736(89)92183-1

PMID:2564495

Abstract

摘要

相似文献

Subcutaneous apomorphine as a diagnostic test for dopaminergic responsiveness in parkinsonian syndromes.皮下注射阿扑吗啡作为帕金森综合征中多巴胺能反应性的诊断试验。

Lancet. 1989 Mar 25;1(8639):675. doi: 10.1016/s0140-6736(89)92183-1.

Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes.预测帕金森综合征中多巴胺能反应性的阿扑吗啡试验。

Lancet. 1990 Jul 7;336(8706):32-4. doi: 10.1016/0140-6736(90)91531-e.

[The apomorphine test for diagnosis of parkinsonian syndrome].[用于帕金森综合征诊断的阿扑吗啡试验]

Riv Neurol. 1990 Nov-Dec;60(6):221-3.

Apomorphine test for dopaminergic responsiveness.

Lancet. 1989 Jun 3;1(8649):1262-3.

[Apomorphine as adjuvant treatment in idiopathic Parkinson syndrome].[阿扑吗啡作为特发性帕金森综合征的辅助治疗]

Schweiz Arch Neurol Psychiatr (1985). 1994;145(5):8-13.

Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.皮下注射阿扑吗啡：关于其在帕金森病中应用的循证综述

Drugs Aging. 2004;21(11):687-709. doi: 10.2165/00002512-200421110-00001.

The apomorphine test in parkinsonian syndromes.帕金森综合征中的阿扑吗啡试验。

J Neurol Neurosurg Psychiatry. 1991 Oct;54(10):870-2. doi: 10.1136/jnnp.54.10.870.

Apomorphine test in parkinsonian syndromes.帕金森综合征的阿扑吗啡试验。

Lancet. 1990 Aug 25;336(8713):518. doi: 10.1016/0140-6736(90)92079-w.

[The apomorphine test in the differential diagnosis of Parkinsonism. Initial experience].[阿扑吗啡试验在帕金森病鉴别诊断中的应用。初步经验]

Cas Lek Cesk. 1994 Nov 7;133(21):665-7.

Subcutaneous apomorphine for parkinsonian patients with psychiatric side effects on oral treatment.皮下注射阿扑吗啡用于对口服治疗有精神副作用的帕金森病患者。

J Neurol Neurosurg Psychiatry. 1991 Apr;54(4):372-3. doi: 10.1136/jnnp.54.4.372.

引用本文的文献

Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson's disease: a systematic review and meta-analysis.帕金森病的多巴胺能反应性及多巴胺能激发试验：一项系统评价与荟萃分析

J Neurol. 2025 Feb 1;272(2):176. doi: 10.1007/s00415-025-12894-8.

Intermittent Apomorphine Use for off Period Rescue in Parkinson's Disease: A Pragmatic Review of over Three Decades of Clinical Experience.间歇性使用阿扑吗啡用于帕金森病“关”期急救：对三十多年临床经验的实用综述

Mov Disord Clin Pract. 2022 Oct 27;10(2):190-208. doi: 10.1002/mdc3.13593. eCollection 2023 Feb.

Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.阿扑吗啡在帕金森病中的应用的药理学研究进展：临床相关性。

Clin Drug Investig. 2018 Apr;38(4):287-312. doi: 10.1007/s40261-018-0619-3.

Role of apomorphine in the treatment of Parkinson's disease.阿扑吗啡在帕金森病治疗中的作用。

CNS Drugs. 2015 Feb;29(2):83-9. doi: 10.1007/s40263-014-0221-z.

Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.皮下注射阿扑吗啡：关于其在帕金森病中应用的循证综述

Drugs Aging. 2004;21(11):687-709. doi: 10.2165/00002512-200421110-00001.

Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study.笔式注射阿扑吗啡治疗晚期帕金森病的“剂末现象”：一项双盲、安慰剂对照研究

J Neurol Neurosurg Psychiatry. 1995 Jun;58(6):681-7. doi: 10.1136/jnnp.58.6.681.

The apomorphine test in parkinsonian syndromes.帕金森综合征中的阿扑吗啡试验。

J Neurol Neurosurg Psychiatry. 1991 Oct;54(10):870-2. doi: 10.1136/jnnp.54.10.870.

Ropinirole (SK and F 101468) in the treatment of Parkinson's disease.罗匹尼罗（SK和F 101468）用于治疗帕金森病。

J Neurol Neurosurg Psychiatry. 1991 Oct;54(10):938. doi: 10.1136/jnnp.54.10.938.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验